32 Result(s)
within
Viviana Maestrini
Angiology
Cardiology
-
Article
Open AccessPrecision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning
Measurement of cardiac structure and function from images (e.g. volumes, mass and derived parameters such as left ventricular (LV) ejection fraction [LVEF]) guides care for millions. This is best assessed usin...
-
Article
Open AccessT2-map** increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study
Early detection of myocardial involvement can be relevant in coronavirus disease 2019 (COVID-19) patients to timely target symptomatic treatment and decrease the occurrence of the cardiac sequelae of the infec...
-
Article
Open AccessHematocrit, iron and HDL-cholesterol explain 90% of variation in native blood T1
-
Article
Open AccessCMR findings in high endurance veteran athletes - a 247 subject study
-
Article
Open AccessNative myocardial T1 and ECV with age and gender develo** normal reference ranges - a 94 healthy volunteer study
-
Article
Open AccessExtracellular volume quantification in isolated hypertension - changes at the detectable limits?
Diffuse myocardial fibrosis (DMF) is important in cardiovascular disease, however until recently could only be assessed by invasive biopsy. We hypothesised that DMF measured by T1 map** is elevated in isolat...
-
Article
Open AccessAbnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
Sarcomeric gene mutations cause hypertrophic cardiomyopathy (HCM). In gene mutation carriers without left ventricular (LV) hypertrophy (G + LVH-), subclinical imaging biomarkers are recognized as predictors of...
-
Article
Open AccessCMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
-
Article
Open AccessMyocardial iron quantification using T2* and native T1map** - a 250 patient study
-
Article
Open AccessAn instantaneous ECV with no blood sampling: using native blood T1 for hematocrit is as good as standard ECV
-
Article
Open AccessLGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
-
Article
Open AccessReproducibility of native myocardial T1 map** in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance
Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in patients with Fabry disease even before left ventricular hypertrophy (LVH) occurs and may be the first non-invasive measure ...
-
Article
Open AccessCardiac amyloid burden assessment by T1 map** predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
-
Article
Open AccessNative T1 map** in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
-
Article
Open AccessAL and ATTR cardiac amyloid are different: native T1 map** and ECV detect different biology
-
Article
Open AccessCMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial
-
Article
Open AccessA simple technique to measure TAPSE and MAPSE on CMR and normal values
-
Article
Open AccessGlobal extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
-
Article
Open AccessT1 map** for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique
-
Article
Open AccessVariable myocardial interstitial expansion by T1 map** within LGE area in infarction and hypertrophic cardiomyopathy
